<DOC>
	<DOCNO>NCT00003723</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness gemcitabine plus cisplatin treating patient malignant mesothelioma pleura remove surgery .</brief_summary>
	<brief_title>S9810 : Gemcitabine Plus Cisplatin Treating Patients With Malignant Mesothelioma Pleura That Can Be Removed Surgery</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate overall survival confirm unconfirmed complete partial response patient unresectable malignant mesothelioma pleura treat gemcitabine plus cisplatin . II . Evaluate qualitative quantitative toxicity regimen patient population . OUTLINE : Patients receive gemcitabine IV 30 minute , immediately follow cisplatin IV 30 minute day 1 , 8 , 15 . Courses repeat every 28 day . Treatment continue absence unacceptable toxicity disease progression . Patients complete response receive 2 additional course therapy . Patients follow every 6 month death . PROJECTED ACCRUAL : A total 50 patient accrue study within 25 month .</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm diagnosis unresectable malignant mesothelioma pleura Epithelial , fibrosarcomatous , mixed type Bidimensionally measurable disease No CNS metastases PATIENT CHARACTERISTICS : Age : Over 18 Performance status : SWOG 02 Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Platelet count least low limit normal Hepatic : Bilirubin great 2.0 mg/dL SGOT SGPT great 2.5 time upper limit normal ( ULN ) Renal : Creatinine great 2 time ULN AND Creatinine clearance least 60 mL/min Other : Not pregnant nursing Fertile patient must use effective contraception No prior malignancy within past 5 year except adequately treat basal squamous cell carcinoma skin , carcinoma situ cervix , adequately treated stage I II cancer currently complete remission Must chest xray within past 28 day PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy No concurrent chemotherapy Endocrine therapy : Concurrent hormone nondiseaserelated condition allow Concurrent steroid antiemesis , adrenal failure , septic shock allow Radiotherapy : No prior radiotherapy No concurrent radiotherapy Surgery : At least 4 week since prior major surgery recover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>advanced malignant mesothelioma</keyword>
	<keyword>epithelial mesothelioma</keyword>
	<keyword>sarcomatous mesothelioma</keyword>
</DOC>